![Muffy Carter](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Muffy Carter
No más puestos en curso
Perfil
Martha J.
Carter formerly worked at Regulatory Affairs Professionals Society, as Director in 1999, Genetics Institute LLC, as Principal, ImmuLogic Pharmaceutical Corp., as Principal, GelTex Pharmaceuticals, Inc., as Vice President-Regulatory Affairs from 1998 to 2002, Proteon Therapeutics, Inc., as Chief Regulatory Officer in 2011, Aegerion Pharmaceuticals, Inc., as Chief Regulatory Officer from 2011 to 2016, Fisons Plc, as Principal, Trine Pharmaceuticals, Inc., as Senior Vice President-Regulatory Affairs from 2002 to 2008, EMD Serono, Inc., as Principal, and Albireo Pharma, Inc., as Chief Regulatory Officer from 2016 to 2023.
Ms. Carter received her undergraduate degree from Northeastern University.
Antiguos cargos conocidos de Muffy Carter.
| Empresas | Cargo | Fin |
|---|---|---|
| ALBIREO PHARMA, INC. | Consejero General | 01/12/2023 |
| AEGERION PHARMACEUTICALS, INC. | Consejero General | 20/07/2016 |
| PROTARA THERAPEUTICS, INC. | Consejero General | 01/02/2011 |
Trine Pharmaceuticals, Inc.
 Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Consejero General | 19/09/2008 |
GelTex Pharmaceuticals, Inc.
 GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Consejero General | 01/01/2002 |
Formación de Muffy Carter.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
64
Relaciones de 1er grado
11
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 11 |
|---|---|
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
ImmuLogic Pharmaceutical Corp.
 ImmuLogic Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
GelTex Pharmaceuticals, Inc.
GelTex Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops non-absorbed, polymer-based pharmaceuticals | Health Technology |
Proteon Therapeutics, Inc.
 Proteon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops pharmaceuticals products for patients with renal and vascular disease | Health Technology |
Aegerion Pharmaceuticals, Inc.
 Aegerion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for hyperlipidemia and metabolic diseases | Health Technology |
Regulatory Affairs Professionals Society
 Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Commercial Services |
Fisons Plc
 Fisons Plc Pharmaceuticals: OtherHealth Technology Manufactures and supplies ethical and proprietary medicines, veterinary products, laboratory and educational scientific equipment, clinical diagnostic supplies and garden products | Health Technology |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Trine Pharmaceuticals, Inc.
Trine Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical products | Health Technology |
EMD Serono, Inc.
 EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology Develops recombinant prescription medicines | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
- Bolsa de valores
- Insiders
- Muffy Carter
